For Industry, Investors and Academia
If you are a quantum hardware vendor excited about the potential use cases of your devices in molecular dynamics and, more generally, in solving problems within the computational drug discovery space, we would love to chat with you. We are building for a future where fault-tolerant quantum computing is realized, but we are also excited to explore the advantages that near-term hardware can bring to this field.
We invite academic and industry laboratories to collaborate with us in advancing transformative drug discovery efforts centered on molecular glues, with a focus on targeting traditionally “undruggable” proteins. As a tech-bio company, we specialize in pioneering the development of novel therapeutics designed to modulate protein-protein interactions (PPIs), creating new opportunities for addressing hard-to-treat diseases. Through collaboration, your lab can harness our state-of-the-art tools and platforms to accelerate the discovery, characterization, and optimization of small molecules for precise modulation of protein function. Together, we can integrate experimental insights with innovative methodologies to unlock the full potential of targeted protein degradation, selective stabilization, or disruption of PPIs, paving the way for groundbreaking solutions in mechanistic drug discovery.
Our company is at the forefront of revolutionizing drug discovery through advanced molecular biology simulations, targeting complex mechanistic insights for more precise therapeutic development. We are dedicated to pushing the boundaries of computational modeling by integrating quantum computing, elevating our ability to tackle multifaceted biological challenges. Our approach is unique in the tech-bio space: we are building a cross-disciplinary team deeply rooted in mathematics, physics, and computation, fostering an environment where cutting-edge science meets real-world impact. We seek investors with expertise in frontier technology who share our long-term vision and commitment to innovation. Together, we can transform the future of drug discovery, setting new standards for both technology and human health.